Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 5/2019

Ausgabe 5/2019

Inhaltsverzeichnis ( 15 Artikel )

06.04.2019 | Commentary | Ausgabe 5/2019

T-cell recognition of non-mutated tumor antigens in healthy individuals: connecting endogenous immunity and tumor dormancy

Constantin N. Baxevanis

19.02.2019 | Original Article | Ausgabe 5/2019 Open Access

Natural T cell autoreactivity to melanoma antigens: clonally expanded melanoma-antigen specific CD8 + memory T cells can be detected in healthy humans

Anna Przybyla, Ting Zhang, Ruliang Li, Diana R. Roen, Andrzej Mackiewicz, Paul V. Lehmann

11.02.2019 | Original Article | Ausgabe 5/2019

Imbalances in cellular immunological parameters in blood predetermine tumor onset in a natural mouse model of breast cancer

Dmitry A. Aronov, Viacheslav V. Zhukov, Svetlana G. Semushina, Ekaterina V. Moiseeva

13.02.2019 | Original Article | Ausgabe 5/2019

Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma

Ying Xiong, Li Liu, Yu Xia, Yangyang Qi, Yifan Chen, Lingli Chen, Peipei Zhang, Yunyi Kong, Yang Qu, Zewei Wang, Zhiyuan Lin, Xiang Chen, Zhuoyi Xiang, Jiajun Wang, Qi Bai, Weijuan Zhang, Yuanfeng Yang, Jianming Guo, Jiejie Xu

21.02.2019 | Original Article | Ausgabe 5/2019

Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma

Izak Faiena, Stephanie H. Astrow, David A. Elashoff, Rajul Jain, Adrian Bot, Karim Chamie, Arie S. Belldegrun, Allan J. Pantuck, Alexandra Drakaki

26.02.2019 | Original Article | Ausgabe 5/2019

Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model

Jamile R. Silva, Natiely S. Sales, Mariângela O. Silva, Luana R. M. M. Aps, Ana C. R. Moreno, Elaine G. Rodrigues, Luís C. S. Ferreira, Mariana O. Diniz

26.02.2019 | Original Article | Ausgabe 5/2019

First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis

Bastian Schilling, Alexander Martens, Marnix H. Geukes Foppen, Christoffer Gebhardt, Jessica C. Hassel, Elisa A. Rozeman, Anja Gesierich, Ralf Gutzmer, Katharina C. Kähler, Elisabeth Livingstone, Panagiotis T. Diamantopoulos, Helen Gogas, Gabriele Madonna, Paolo A. Ascierto, Simone M. Goldinger, Johanna Mangana, Claus Garbe, Dirk Schadendorf, Christian Blank, Benjamin Weide

11.02.2019 | Clinical Trial Report | Ausgabe 5/2019 Open Access

Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2

Linh T. Nguyen, Samuel D. Saibil, Valentin Sotov, Michael X. Le, Leila Khoja, Danny Ghazarian, Luisa Bonilla, Habeeb Majeed, David Hogg, Anthony M. Joshua, Michael Crump, Norman Franke, Anna Spreafico, Aaron Hansen, Ayman Al-Habeeb, Wey Leong, Alexandra Easson, Michael Reedijk, David P. Goldstein, David McCready, Kazuhiro Yasufuku, Thomas Waddell, Marcelo Cypel, Andrew Pierre, Bianzheng Zhang, Sarah Boross-Harmer, Jane Cipollone, Megan Nelles, Elizabeth Scheid, Michael Fyrsta, Charlotte S. Lo, Jessica Nie, Jennifer Y. Yam, Pei Hua Yen, Diana Gray, Vinicius Motta, Alisha R. Elford, Stephanie DeLuca, Lisa Wang, Stephanie Effendi, Ragitha Ellenchery, Naoto Hirano, Pamela S. Ohashi, Marcus O. Butler

11.02.2019 | Clinical Trial Report | Ausgabe 5/2019 Open Access

Metronomic cyclophosphamide attenuates mTOR-mediated expansion of regulatory T cells, but does not impact clinical outcome in patients with metastatic renal cell cancer treated with everolimus

Inge M. Werter, Charlotte M. Huijts, Sinéad. M. Lougheed, Paul Hamberg, Marco B. Polee, Metin Tascilar, Maartje Los, John B. A. G. Haanen, Helgi H. Helgason, Henk M. Verheul, Tanja D. de Gruijl, Hans J. van der Vliet, for the Dutch WIN-O Consortium

15.02.2019 | Clinical Trial Report | Ausgabe 5/2019

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

Martin Sebastian, Andreas Schröder, Birgit Scheel, Henoch S. Hong, Anke Muth, Lotta von Boehmer, Alfred Zippelius, Frank Mayer, Martin Reck, Djordje Atanackovic, Michael Thomas, Folker Schneller, Jan Stöhlmacher, Helga Bernhard, Andreas Gröschel, Thomas Lander, Jochen Probst, Tanja Strack, Volker Wiegand, Ulrike Gnad-Vogt, Karl-Josef Kallen, Ingmar Hoerr, Florian von der Muelbe, Mariola Fotin-Mleczek, Alexander Knuth, Sven D. Koch

19.08.2018 | Focussed Research Review | Ausgabe 5/2019

Monitoring of patients with metastatic melanoma treated with immune checkpoint inhibitors using PET–CT

Antonia Dimitrakopoulou-Strauss

09.10.2018 | Focussed Research Review | Ausgabe 5/2019

Opposing roles of eosinophils in cancer

Sonja C. S. Simon, Jochen Utikal, Viktor Umansky

07.11.2018 | Focussed Research Review | Ausgabe 5/2019

Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism

Jingjing Zhu, Pierre-Florent Petit, Benoit J. Van den Eynde

21.11.2018 | Focussed Research Review | Ausgabe 5/2019 Open Access

An alphavirus-based therapeutic cancer vaccine: from design to clinical trial

Amrita Singh, Georgia Koutsoumpli, Stephanie van de Wall, Toos Daemen

05.04.2019 | Focussed Research Review | Ausgabe 5/2019

Modulation of NK cells with checkpoint inhibitors in the context of cancer immunotherapy

Beatriz Sanchez-Correa, Nelson Lopez-Sejas, Esther Duran, Fernando Labella, Corona Alonso, Rafael Solana, Raquel Tarazona

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise